Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria.
about
Review: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaDrug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of ChinaChange of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme.Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa.Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiationPopulation-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverageRetention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South AfricaTrends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study.The therapeutic landscape of HIV-1 via genome editingReductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.Editorial commentary: immunodeficiency at start of antiretroviral therapy: the persistent problem of late presentation to care.Barriers to antiretroviral treatment initiation in rural KwaZulu-Natal, South Africa.Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa.Integrating HIV and hypertension management in low-resource settings: Lessons from Malawi.Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
P2860
Q27022927-798E1CC1-6BFF-4716-A096-560A1C03A24AQ28354095-6DCFEB22-8E08-415E-8EFF-AE1A0DFADE98Q31010333-1AC9D5CD-A22B-4845-8901-FC1DA7E2317DQ33892396-71C5081D-538B-4D43-9233-43143CF1C1B9Q34633232-43D2A92A-06F9-4EBE-A04D-DC56DC6D1B25Q34875528-AE3C4627-3F76-49C1-89DC-49BD641EFCFFQ35576031-F2EC1CDB-EECA-4D42-9773-18E85CE8C4FBQ36380146-F0A12EBB-8F0E-433A-B43A-2BE379EB629DQ36458524-09A52814-233D-4326-80DA-E3DAAABE306EQ36619830-74C9B09D-A662-4265-B5AD-2D5566A07B7EQ37701865-14E57413-6C45-4B74-9008-1D8AB24C0D84Q39153976-562AF86D-3502-4A2E-A309-8B289533056AQ42149889-1D8156B4-9188-450E-8C3C-D64D32F72686Q43184103-1F2B493F-92BE-4BE2-AD1B-23A85BC0615FQ46139842-DBD97F25-1D2C-4C20-BF57-9F275B9BD8E5Q46570650-C29B9AAF-1B8A-4D9E-9728-537950D034DCQ55016986-B2BA3487-3A04-4324-B0AE-D7ADE785C33DQ58774654-FF88873C-C812-4FB5-9A39-FF1CBEE4E8EF
P2860
Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduction in early mortality o ...... ll count eligibility criteria.
@en
Reduction in early mortality o ...... ll count eligibility criteria.
@nl
type
label
Reduction in early mortality o ...... ll count eligibility criteria.
@en
Reduction in early mortality o ...... ll count eligibility criteria.
@nl
prefLabel
Reduction in early mortality o ...... ll count eligibility criteria.
@en
Reduction in early mortality o ...... ll count eligibility criteria.
@nl
P2860
P50
P1476
Reduction in early mortality o ...... ll count eligibility criteria.
@en
P2093
Portia C Mutevedzi
P2860
P304
P356
10.1097/QAI.0B013E31829CEB14
P407
P577
2014-01-01T00:00:00Z